Complete pathological regression of hepatocellular carcinoma with portal vein thrombosis treated with sorafenib

Sorafenib is a molecular-targeted therapy used in palliative treatment of advanced hepatocellular carcinoma (HCC) in Child-Pugh A patients. We describe the case of a patient who presented with a large HCC in the left liver associated with portal vein thrombosis (PVT). After 9 months of sorafenib tre...

Full description

Saved in:
Bibliographic Details
Main Authors: Kermiche-Rahali, Sabrina, Di Fiore, Aude, Drieux, Fanny, Di Fiore, Frédéric, François, Arnaud, Scotté, Michel
Format: Artigo
Language:Inglês
Published: BioMed Central 2013
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3735470/
https://ncbi.nlm.nih.gov/pubmed/23914915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-11-171
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items